Procalcitonin biomarker kinetics fails to predict treatment response in perioperative abdominal infection with septic shock
- PMID: 24156734
- PMCID: PMC4056026
- DOI: 10.1186/cc13082
Procalcitonin biomarker kinetics fails to predict treatment response in perioperative abdominal infection with septic shock
Abstract
Introduction: Procalcitonin (PCT) biomarker is suggested to tailor antibiotic therapy in the medical intensive care unit (ICU) but studies in perioperative medicine are scarce. The aim of this study was to determine whether PCT reported thresholds are associated with the initial treatment response in perioperative septic shock secondary to intra-abdominal infection.
Methods: This single ICU, observational study included patients with perioperative septic shocks secondary to intra-abdominal infection. Demographics, PCT at days 0, 1, 3, 5, treatment response and outcome were collected. Treatment failure included death related to the initial infection, second source control treatment or a new onset intra-abdominal infection. The primary endpoint was to assess whether PCT thresholds (0.5 ng/ml or a drop from the peak of at least 80%) predict the initial treatment response.
Results: We included 101 consecutive cases. Initial treatment failed in 36 patients with a subsequent mortality of 75%. Upon admission, PCT was doubled when treatment ultimately failed (21.7 ng/ml ± 38.7 vs. 41.7 ng/ml ± 75.7; P = 0.04). Although 95% of the patients in whom PCT dropped down below 0.5 ng/ml responded to treatment, 50% of the patients in whom PCT remained above 0.5 ng/ml also responded successfully to treatment. Moreover, despite a PCT drop of at least 80%, 40% of patients had treatment failure.
Conclusions: In perioperative intra-abdominal infections with shock, PCT decrease to 0.5 ng/ml lacked sensitivity to predict treatment response and its decrease of at least 80% from its peak failed to accurately predict treatment response. Studies in perioperative severe infections are needed before using PCT to tailor antibiotic use in this population.
Figures



Comment in
-
Monitoring treatment response in abdominal sepsis with procalcitonin--if only!Crit Care. 2013 Dec 10;17(6):1017. doi: 10.1186/cc13154. Crit Care. 2013. PMID: 24326175 Free PMC article.
Similar articles
-
Usefulness of procalcitonin for diagnosis of infection in cardiac surgical patients.Crit Care Med. 2000 Sep;28(9):3171-6. doi: 10.1097/00003246-200009000-00008. Crit Care Med. 2000. PMID: 11008977
-
Procalcitonin-guided therapy may reduce length of antibiotic treatment in intensive care unit patients with secondary peritonitis: A multicenter retrospective study.J Crit Care. 2015 Jun;30(3):537-42. doi: 10.1016/j.jcrc.2014.12.014. Epub 2014 Dec 31. J Crit Care. 2015. PMID: 25600574
-
Monitoring treatment response in abdominal sepsis with procalcitonin--if only!Crit Care. 2013 Dec 10;17(6):1017. doi: 10.1186/cc13154. Crit Care. 2013. PMID: 24326175 Free PMC article.
-
The efficacy of procalcitonin as a biomarker in the management of sepsis: slaying dragons or tilting at windmills?Surg Infect (Larchmt). 2013 Dec;14(6):489-511. doi: 10.1089/sur.2012.028. Epub 2013 Nov 25. Surg Infect (Larchmt). 2013. PMID: 24274059 Review.
-
Serum procalcitonin in the diagnosis and management of intra-abdominal infections.Expert Rev Anti Infect Ther. 2012 Feb;10(2):197-205. doi: 10.1586/eri.11.164. Expert Rev Anti Infect Ther. 2012. PMID: 22339193 Review.
Cited by
-
A Focus on Intra-Abdominal Sepsis with Biomarkers: A Literature Review.Eurasian J Med. 2022 Dec;54(Suppl1):66-70. doi: 10.5152/eurasianjmed.2022.22296. Eurasian J Med. 2022. PMID: 36655448 Free PMC article.
-
Management of intra-abdominal infections: recommendations by the WSES 2016 consensus conference.World J Emerg Surg. 2017 May 4;12:22. doi: 10.1186/s13017-017-0132-7. eCollection 2017. World J Emerg Surg. 2017. PMID: 28484510 Free PMC article. Review.
-
Importance of Source Control in the Subgroup of Intra-Abdominal Infections for Septic Shock Patients: Analysis of 390 Cases.Mediterr J Hematol Infect Dis. 2024 Jul 1;16(1):e2024051. doi: 10.4084/MJHID.2024.051. eCollection 2024. Mediterr J Hematol Infect Dis. 2024. PMID: 38984090 Free PMC article.
-
Procalcitonin: Where Are We Now?Crit Care Clin. 2020 Jan;36(1):23-40. doi: 10.1016/j.ccc.2019.08.003. Epub 2019 Oct 21. Crit Care Clin. 2020. PMID: 31733680 Free PMC article. Review.
-
Short-course antibiotic therapy for critically ill patients treated for postoperative intra-abdominal infection: the DURAPOP randomised clinical trial.Intensive Care Med. 2018 Mar;44(3):300-310. doi: 10.1007/s00134-018-5088-x. Epub 2018 Feb 26. Intensive Care Med. 2018. PMID: 29484469 Clinical Trial.
References
-
- Goldmann DA, Weinstein RA, Wenzel RP, Tablan OC, Duma RJ, Gaynes RP, Schlosser J, Martone WJ. Strategies to prevent and control the emergence and spread of antimicrobial-resistant microorganisms in hospitals. A challenge to hospital leadership. JAMA. 1996;17:234–240. doi: 10.1001/jama.1996.03530270074035. - DOI - PubMed
-
- Chastre J, Wolff M, Fagon J-Y, Chevret S, Thomas F, Wermert D, Clementi E, Gonzalez J, Jusserand D, Asfar P, Perrin D, Fieux F, Aubas S. Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial. JAMA. 2003;17:2588–2598. doi: 10.1001/jama.290.19.2588. - DOI - PubMed
-
- Singh N, Rogers P, Atwood CW, Wagener MM, Yu VL. Short-course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit. A proposed solution for indiscriminate antibiotic prescription. Am J Respir Crit Care Med. 2000;17:505–511. doi: 10.1164/ajrccm.162.2.9909095. - DOI - PubMed
-
- Nobre V, Harbarth S, Graf J-D, Rohner P, Pugin J. Use of procalcitonin to shorten antibiotic treatment duration in septic patients: a randomized trial. Am J Respir Crit Care Med. 2007;17:498–505. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources